LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.31623
 58.15 27.76 83 5906 0.0141 0.1522
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
 58.15 27.76 892 5906 0.1510 0.5663
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
 59.85 27.76 114 6062 0.0188 0.1994
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
 59.85 27.76 804 6062 0.1326 0.5421
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
 59.85 27.76 84 6062 0.0139 0.1531
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
 59.85 27.76 1070 6062 0.1765 0.5999
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
 61.56 27.76 120 6217 0.0193 0.2063
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
 61.56 27.76 908 6217 0.1461 0.5632
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
 61.56 27.76 90 6217 0.0145 0.1626
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
 61.56 27.76 1114 6217 0.1792 0.6047
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
 63.26 27.76 123 6465 0.0190 0.2084
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
 63.26 27.76 916 6465 0.1417 0.5599
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
 63.26 27.76 89 6465 0.0138 0.1597
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
 63.26 27.76 1136 6465 0.1757 0.6032
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
 64.97 27.76 136 6656 0.0204 0.2226
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
 64.97 27.76 1056 6656 0.1586 0.5845
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
 64.97 27.76 96 6656 0.0144 0.1699
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
 64.97 27.76 1115 6656 0.1675 0.5954
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
 66.67 27.76 131 6695 0.0196 0.2166
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
 66.67 27.76 942 6695 0.1407 0.5610
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
 66.67 27.76 108 6695 0.0161 0.1873
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
 66.67 27.76 1142 6695 0.1706 0.5995
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
 68.37 27.76 149 6879 0.0217 0.2353
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
 68.37 27.76 1007 6879 0.1464 0.5707
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
 68.37 27.76 100 6879 0.0145 0.1749
MN20160318_Q01
I20